$1.71
-0.16-8.56%
Last update: Nov 5, 11:27 AM
Voyager Therapeutics Inc
VYGRNASDAQ
Voyager Therapeutics (VYGR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.52 | $-0.54 | $-0.52 | $-0.52 |
| Actual | $-0.40 | $-0.47 | $-0.46 | $-0.47 |
| Surprise | +23.1% | +13.0% | +11.5% | +9.62% |
| Revenue | ||||
| Estimate | $4.3M | $9.0M | $10.2M | $8.1M |
| Actual | $3.2M | $2.6M | $15.3M | $13.4M |
| Surprise | -27.2% | -71.3% | +50.7% | +64.6% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.42 | $-0.39 | $-0.26 | $-0.26 |
| Revenue | ||||
| Consensus | $6.0M | $8.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.40 | $-0.52 | 23.1 % |
| Q1 | May 7, 2026 | $-0.47 | $-0.54 | 13.0 % |
| Q4 | Mar 9, 2026 | $-0.46 | $-0.52 | 11.5 % |
| Q3 | Nov 10, 2025 | $-0.47 | $-0.52 | 9.62 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $3.17M | $4.35M | -27.2 % |
| Q1 | May 7, 2026 | $2.59M | $9.03M | -71.3 % |
| Q4 | Mar 9, 2026 | $15.34M | $10.18M | 50.7 % |
| Q3 | Nov 10, 2025 | $13.37M | $8.12M | 64.6 % |
